Transplant biotech eGenesis snags $191M after first use of gene-edited pig kidney

Fol­low­ing a world-first trans­plant ear­li­er this year, eGe­n­e­sis has raised $191 mil­lion to con­tin­ue de­vel­op­ing ge­net­i­cal­ly mod­i­fied pig or­gans for peo­ple in dire need of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.